Patients who use cannabis reduce their use in medications for pain, anxiety, migraine and sleep disorders

Patients who use cannabis reduce their use in medications for pain, anxiety, migraine and sleep disorders

By: IACM Medical

In an online survey of 1,513 patients, who receive cannabis from dispensaries, researchers from different scientific institutions across the USA revealed that a large number significantly reduced their use of several other medications.

Among respondents that regularly used opioids, over three-quarters (76.7%) indicated that they reduced their use since they started the medical use of cannabis. Approximately two-thirds of patients decreased their use of anti-anxiety drugs (71.8%), followed by medications for migraine (66.7%), sleep disorders (65.2%), alcohol (42.0%) and antidepressants (37.6%). Authors wrote that “a majority of patients reported using les opioids as well as fewer medications to treat anxiety, migraines, and sleep after initiating MC [medical cannabis]”.

Piper BJ, DeKeuster RM, Beals ML, Cobb CM, Burchman CA, Perkinson L, Lynn ST, Nichols SD, Abess AT. Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. J Psychopharmacol. 2017 Mar 1. [in press]

Source: IACM Bulletin

Kannabia Seeds Company sells to its customers a product collection, a souvenir. We cannot and we shall not give growing advice since our product is not intended for this purpose.

Kannabia accept no responsibility for any illegal use made by third parties of information published. The cultivation of cannabis for personal consumption is an activity subject to legal restrictions that vary from state to state. We recommend consultation of the legislation in force in your country of residence to avoid participation in any illegal activity.

Share: